# Link Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/link-medical

- Headquarters: Hangzhou, China
- Website: www.lkmed.com.cn/
- Latest round: Series A (Dec 15, 2025)
- Investors on record: 1

## About

Based in China, Link Medical Technology focuses on developing advanced temperature control systems aimed at enhancing medical care, particularly in cardiovascular disease management and critical care scenarios.Link Medical Technology, founded in 2022 in Hangzhou, China, specializes in innovative temperature control solutions for healthcare. The company has secured one deal, with its most recent funding round occurring on December 15, 2025.Link Medical specializes in advanced temperature control systems designed to enhance medical care, particularly in the management and treatment of cardiovascular diseases and critical care scenarios. Their core product offerings leverage proprietary technology to facilitate rapid updates and iterations, ensuring that the products meet the evolving needs of healthcare professionals and patients alike. These solutions are primarily aimed at hospitals and healthcare facilities, focusing on improving patient outcomes by reducing morbidity and mortality rates associated with severe medical conditions. The company's products are strategically marketed across multiple regions, including Southeast Asia, Europe, and North America, targeting a diverse range of end users from large medical institutions to smaller clinics.Link Medical operates on a B2B model, primarily engaging with healthcare providers and institutions through direct sales and partnerships. Revenue is generated through the sale of their temperature control systems, which may be bundled with services such as installation, training, and ongoing maintenance support. While specific pricing plans for their flagship products have not been disclosed, the company employs a tiered pricing structure that adjusts based on the scale and customization level required by clients. The emphasis on high-quality medical products indicates that transactions are designed to foster long-term relationships, with ongoing service agreements potentially supplementing initial equipment sales for sustained revenue growth.In December 2025, Link Medical raised an undisclosed amount of Series A funding from new investor Delian Capital. The company will utilize this funding to accelerate product development, conduct clinical trials, and expand into new markets, further consolidating its technological advantages in the field of intelligent temperature-controlled therapy.

## Funding rounds

- Series A, Dec 15, 2025 — Delian Capital

## Investors

- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series A